Last updated on November 2017

Major Cardiovascular Events Study

Brief description of study

Major Cardiovascular Events Study

Detailed Study Description

Phase 3 Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Evaluation of the Efficacy, Safety, and Tolerability of a Research Medication in Reducing the Occurrence of Major Cardiovascular Events

Clinical Study Identifier: TX3487

Contact Investigators or Research Sites near you

Start Over

Ashley Nalley

Atlanta Center for Medical Research
Atlanta, GA USA